AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0

CUSIP: 00163UAD8

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Debt / NOTE 3.250% 6/0
Market price (% of par)
104.85%
Total 13F principal
$302,125,000
Principal change
+$4,037,500
Total reported market value
$316,695,000
Number of holders
26
Value change
+$4,316,712
Number of buys
6
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 00163UAD8?
CUSIP 00163UAD8 identifies 00163UAD8 - AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 as of Q3 2018

As of 30 Sep 2018, AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 was held by 26 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $302,125,000 in principal (par value) of the bond. The largest 10 bondholders included STEELHEAD PARTNERS LLC, TENOR CAPITAL MANAGEMENT Co., L.P., Allianz Asset Management GmbH, CNH PARTNERS LLC, WOLVERINE ASSET MANAGEMENT LLC, CAMDEN ASSET MANAGEMENT L P /CA, CALAMOS ADVISORS LLC, Context Partners Fund, L.P., Context Capital Management, LLC, and CITADEL ADVISORS LLC. This page lists 26 institutional bondholders reporting positions for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.